Predictors of outcome in phaeochromocytomas and paragangliomas.

about

Predictors of outcome in phaeochromocytomas and paragangliomas.

Item

http://www.wikidata.org/entity/Q48246997

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Predictors of outcome in phaeochromocytomas and paragangliomas.

@en

Predictors of outcome in phaeochromocytomas and paragangliomas.

@nl

type

Item

label

Predictors of outcome in phaeochromocytomas and paragangliomas.

@en

Predictors of outcome in phaeochromocytomas and paragangliomas.

@nl

prefLabel

Predictors of outcome in phaeochromocytomas and paragangliomas.

@en

Predictors of outcome in phaeochromocytomas and paragangliomas.

@nl

P1476

Predictors of outcome in phaeochromocytomas and paragangliomas

@en

P2093

Marlo Nicolas

http://www.w3.org/2001/XMLSchema#string

P2860

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma

Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma

Mitochondrial Deficiencies in the Predisposition to Paraganglioma

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.

Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.

An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges.

Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.

P304

2160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.12419.1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patricia L M Dahia

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29333259

http://www.w3.org/2001/XMLSchema#string

P932

5749134

http://www.w3.org/2001/XMLSchema#string